Predominant neuritic pathology induced by viral overexpression of α-synuclein in cell culture

Cellular and Molecular Neurobiology

Volumn 27, Issue 4, 2007, Pages 505-515

  Zach, S ^a   Bueler, H ^b   Hengerer, B ^a   Gillardon, F ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adeno associated virus; Mesencephalic neurons; Neuritic swellings; Neurodegeneration; Parkinson's disease; Truncated synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CEREBELLUM; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYO; EXPRESSION VECTOR; FETUS; GENE OVEREXPRESSION; GRANULE CELL; MESENCEPHALON; MUTATION; NERVE CELL CULTURE; NERVE DEGENERATION; NEURITE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; RAT; TRANSGENE;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DEPENDOVIRUS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; NEURONS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; SENILE PLAQUES; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; CYTOMEGALOVIRUS; MUS MUSCULUS;

EID: 34248595982     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-007-9141-5     Document Type: Article

References (37)

1. Bianco, C. L., Ridet, J. L., Dchneider, B. L., Deglon, N., and Aebischer, P. (2002). α-Synuclein and selective dopaminergic neuron loss in a rat lentiviral model of Parkinson's disease. PNAS 99:10813-10818.
2. Bottenstein, J., Skaper, S., Varon, S., and Sato, G. (1980). Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium. Exp. Cell. Res. 30:183-190.
3. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., and Del Tredici, K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318:121-134.
4. Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., and Südhof, T. C. (2005). α-Synuclein cooperates with CSPa in preventing neurodegeneration. Cell 123:383-396.
5. Dong, Z., Ferger, B., Feldon, J., and Büeler, H. (2002). Overexpression of Parkinson's disease-associated α-synuclein(A53T) by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. J. Neurobiol. 53:1-10.
6. Duda, J. E., Giasson, B. I., Mabon, M. E., Lee, V. Y., and Trojanowski, J. Q. (2002). Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann. Neurol. 52:205-210.
7. Ehrengruber, M. U., Hennou, S., Büeler, H., Naim, H. Y., Déglon, N., and Lundstrom, K. (2001). Gene transfer into neurons from hippocampal slices: Comparison of recombinant semliki forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol. Cell. Neurosci. 17:855-871.
8. Jensen, P. H., Islam, K., Kenney, J., Nielsen, M. S., Power, J., and Gai, W. P. (2000). Microtubuleassociated protein 1B is a component of cortical Lewy Bodies and binds α-synuclein filaments. J. Biol. Chem. 275:21500-21507.
9. Kirik, D., Rosenblad, C., Burger, C., Lunberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., and Björklund, A. (2002). Parkinson-Like neurodegeneration induced by targeted overexpression of α-synuclein in the nigrostratial system. J. Neurosci. 22:2780-2791.
10. Kontopolous, E., Parvin, J. D., Feany, M. B. (2006). α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet. 15(20):3012-3023.
11. Kotzbauer, P. T., Giasson, B. I., Kravitz, A. V., Golbe, L. I., Mark, M. H., Trojanowski, J. Q., and Lee, V. M. (2004). Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation. Exp. Neurol. 18:279-288.
12. + toxicity. EMBO J. 14:736-742.
13. Krüger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L., and Riess, O. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18(2):106-108.
14. Kumlesh, K. D., Hofele, K., Barbieri, S., Buchman, V. L., and Van Der Putten, H. (2003). Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45:14-44.
15. Li, W., West, N., Colla, E., Pletnikova, O., Troncoso, J. C., Marsh, L., Dawson, T. M., Jäkälä, P., Hartmann, T., Price, D. L., and Lee, M. K. (2005). Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's diseaselinked mutations. PNAS 102:2162-2167.
16. Liu, C. W., Giasson, B. I., Lewis, K. A., Lee, V. M., DeMartino, G. N., and Thomas, P. J. (2005). A precipitating role for truncated α-synuclein and the proteasome in α-synuclein aggregation. J. Biol. Chem. 280:22670-22678.
17. Machida, Y., Chiba, T., Takayanagi, A., Tanaka, Y., Asanuma, M., Ogawa, N., Koyama, A., Iwatsubo, T., Ito, S., Jansen, P. H., Shimizu, N., Tanaka, K., Mizuno, Y., and Hattori, N. (2005). Common anti-apoptotic roles of parkin and α-synuclein in human dopaminergic cells. Biochem. Biophys. Res. Commun. 332:233-240.
18. Maingay, M., Romero-Ramos, M., Carta, M., and Kirik, D. (2006). Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol. Dis. 23:522-532.
19. Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., and Lee, M. K. (2006). Parkinson's disease α-Synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26:41-50.
20. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., Louis, J. C., Wypych, J., Biere, A. L., and Citron, M. (1999). Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274:9843-9846.
21. Neve, R. L., Neve, K. A., Nestler, E. J., and Carlezon, W. A. (2005). Use of herpes virus amplicon vectors to study brain disorders. Biotechniques 39:381-391.
22. Panday, N., Schmidt, R. E., and Galvin, J. E. (2006). The alpha-synuclein mutation E46K promotes aggregation in cultured cells. Exp. Neurol. 197:515-520.
23. Petrucelli, L., O'Farrell, C., Lockhart, P. J., Baptsita, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J., and Cookson, M. R. (2002). Parkin protects against the toxicity associated with mutant α-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36:1007-1019.
24. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Die, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubensstain, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinsons's disease. Science 276:2045-2047.
25. Quist, A., Doudeviski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., and Lal, R. (2005). Amyloid ion channels: A common structural link for protein-misfolding disease. PNAS 102:10427- 10432.
26. Raisler, B. J., Berns, K. I., Grant, M. B., Beliaev, D., and Hauswirth, W. W. (2002). Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularisation. Proc. Natl. Acad. Sci. U.S.A. 99:8909-8914.
27. Shibata, H., Katsuki, H., Nishiwaki, M., Kume, T., Kaneko, S., and Akaike, A. (2003). Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: Role of inducible nitric oxide synthase and protection by indomethcin. J. Neurochem. 86:1201-1212.
28. Shults, C. W. (2006). Lewy bodies. PNAS 103:1661-1668.
29. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M. R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn-Hardy, K. (2003). Alpha-synuclein locus triplication causes Parkinson's Disease. Science 302:841.
30. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). Alpha synuclein in Lewy bodies. Nature 388:839-840.
31. Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., and Goldstein, L. S. B. (2005). Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-1288.
32. Stoppini, L., Buchs, P. A., and Muller, D. (1991). A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37:173-182.
33. Tofaris, G. K., Reitböck, P. G., Humby, T., Lambourne, S. L., O'Connell, M., Ghetti, B., Gossage, H., Emson, P. C., Wilkinson, L. S., Goedert, M., and Spillantini, M. G. (2006). Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): Implications for Lewy body disorders. J. Neurosci. 26:3942-3950.
34. Wilkemeyer, M. F., Smith, K. L., Zarei, M. M., Benke, T. A., Swann, J. W., Angelides, K. J., and Eisensmith, R. C. (1996). Adenovirus-mediated gene transfer into dissociated and explant cultures of rat hippocampal neurons. J. Neurosci. Res. 43:161-174.
35. Yamada, M., Iwatsubo, T., Mizuno, Y., and Mochizuk, I. H. (2004). Overexpression of α-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phophorylation of α-synuclein and activation of caspase-9: Resemblance to pathogenetic changes in Parkinson's disease. J. Neurochem. 91:451-461.
36. Yamaguchi, K., Chochran, E. J., Murell, J. R., Polymeropolous, M. H., Shannon, K. M., Crowther, R. A., Goedert, M., and Ghetti, B. (2005). Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene. Acta Neuropathol. 110:298-305.
37. Zhou, W., Hurlbert, M. S., Schaack, J., Prasdad, K. N., and Freed, C. R. (2000). Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalonderived cells. Brain Res. 866:33-43.